Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
The University of Melbourne · Austin Health · +6 more institutions
Abstract
CONTEXT: Although glycated hemoglobin A1c is currently the best parameter used clinically to assess risk for the development of diabetes complications, it does not provide insight into short-term fluctuations in glucose levels. This review summarizes the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications. EVIDENCE ACQUISITION: PubMed and Embase databases were searched from January 1, 2010 to August 22, 2020, using the terms type 1 diabetes, type 2 diabetes, diabetes-related microvascular and macrovascular complications, and measures of glycaemic variability. Exclusion criteria were studies that did not use CGM and studies…
Citation impact
- FWCI
- 31.17
- Percentile
- 100%
- References
- 83
Authors
5- MYMichael Yapanis
The University of Melbourne, Austin Health
- SJSteven James
University of the Sunshine Coast
- MEMaria E. Craig
The University of Sydney, Children's Hospital at Westmead, UNSW Sydney, Sydney Children's Hospital
- DNDavid N. O’Neal
The University of Melbourne, St Vincent's Hospital Melbourne
- EIElif I. EkinciCorresponding
The University of Melbourne, Austin Health
Topics & keywords
- Medicine
- Diabetes mellitus
- Glycemic
- Type 2 diabetes
- Internal medicine
- Glycated hemoglobin
- Macrovascular disease
- Type 1 diabetes
- Good health and well-being